Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3235 Target Snapshot

Isoleucine--tRNA ligase, cytoplasmic · SINGLE PROTEIN · Homo sapiens

80Compounds
14Assays
1Approved Drugs
84.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P41252. Use UniProt P41252 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P41252 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Isoleucine--tRNA ligase, cytoplasmic as ChEMBL target CHEMBL3235, mapped to UniProt P41252. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Isoleucine--tRNA ligase, cytoplasmic
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3235
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P41252
Isoleucine--tRNA ligase, cytoplasmic
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Isoleucine--tRNA ligase, cytoplasmic is the right protein anchor across sources, using UniProt P41252 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelIsoleucine--tRNA ligase, cytoplasmic
UniProt AccessionP41252
Component TypeProtein
Sequence Length1262 aa

Isoleucine--tRNA ligase, cytoplasmic

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Isoleucine--tRNA ligase, cytoplasmic, mapped to UniProt P41252. Sequence length is 1262 aa.

Mapped IDP41252
Review nameIsoleucine--tRNA ligase, cytoplasmic
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5082.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL719 9.1 IC50 0.8 Approved
CHEMBL605376 7.85 IC50 14.0 Preclinical
CHEMBL125075 7.82 IC50 15.0 Preclinical
CHEMBL340359 7.7 IC50 20.0 Preclinical
CHEMBL125820 7.52 IC50 30.0 Preclinical
CHEMBL538163 7.52 IC50 30.0 Preclinical
CHEMBL605592 7.41 IC50 39.0 Preclinical
CHEMBL125221 7.35 IC50 45.0 Preclinical
CHEMBL3752910 7.03 Kd 94.41 Preclinical
CHEMBL1163069 7.01 IC50 98.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
3
5.5
3
6.0
7
6.5
9
7.0
5
7.5
0
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MUPIROCIN
CHEMBL719
Approved 1987
Assay Landscape

Assay Landscape

14
Total Assays
42
Tested Compounds
2
Assay Types
Binding — 10 assays, 42 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 9 42 6.0
cell-based format 1 0
Functional — 4 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine